Cadila Healthcare informs about press release

27 Nov 2018 Evaluate

Cadila Healthcare has informed about submission of a copy of press release dated November 27, 2018 titled ‘Zydus receives final approval from the USFDA for Baclofen Tablets’.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

891.15 14.80 (1.69%)
20-Mar-2026 12:47 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1774.00
Dr. Reddys Lab 1296.90
Cipla 1257.15
Zydus Lifesciences 891.15
Lupin 2316.65
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×